A detailed history of Aristotle Atlantic Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Aristotle Atlantic Partners, LLC holds 240,542 shares of BSX stock, worth $22 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
240,542
Previous 233,209 3.14%
Holding current value
$22 Million
Previous $18 Million 12.24%
% of portfolio
0.63%
Previous 0.58%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $535,015 - $615,972
7,333 Added 3.14%
240,542 $20.2 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $15.7 Million - $18.1 Million
233,209 New
233,209 $18 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $131B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Aristotle Atlantic Partners, LLC Portfolio

Follow Aristotle Atlantic Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.